Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity.

Olson ES, Whitney MA, Friedman B, Aguilera TA, Crisp JL, Baik FM, Jiang T, Baird SM, Tsimikas S, Tsien RY, Nguyen QT.

Integr Biol (Camb). 2012 Jun;4(6):595-605. doi: 10.1039/c2ib00161f. Epub 2012 Apr 26.

PMID:
22534729
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

In vivo biodistribution of radiolabeled MMP-2/9 activatable cell-penetrating peptide probes in tumor-bearing mice.

van Duijnhoven SM, Robillard MS, Nicolay K, Grüll H.

Contrast Media Mol Imaging. 2014 May 13. doi: 10.1002/cmmi.1605. [Epub ahead of print]

PMID:
24823643
[PubMed - as supplied by publisher]
3.

Detection and monitoring of localized matrix metalloproteinase upregulation in a murine model of asthma.

Felsen CN, Savariar EN, Whitney M, Tsien RY.

Am J Physiol Lung Cell Mol Physiol. 2014 Apr 15;306(8):L764-74. doi: 10.1152/ajplung.00371.2013. Epub 2014 Feb 7.

PMID:
24508733
[PubMed - indexed for MEDLINE]
4.

Cy5.5-Conjugated matrix metalloproteinase cleavable peptide nanoprobe.

Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2012 Mar 19 [updated 2012 Apr 12].

PMID:
22514808
[PubMed]
Books & Documents
5.

Imaging of MMP activity in postischemic cardiac remodeling using radiolabeled MMP-2/9 activatable peptide probes.

van Duijnhoven SM, Robillard MS, Hermann S, Kuhlmann MT, Schäfers M, Nicolay K, Grüll H.

Mol Pharm. 2014 May 5;11(5):1415-23. doi: 10.1021/mp400569k. Epub 2014 Apr 9.

PMID:
24641497
[PubMed - in process]
6.

Molecular targeting of atherosclerotic plaques by a stabilin-2-specific peptide ligand.

Lee GY, Kim JH, Oh GT, Lee BH, Kwon IC, Kim IS.

J Control Release. 2011 Oct 30;155(2):211-7. doi: 10.1016/j.jconrel.2011.07.010. Epub 2011 Jul 14.

PMID:
21781994
[PubMed - indexed for MEDLINE]
7.

Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin: comparison with heparin and recombinant Hirudin.

Berry CN, Girardot C, Lecoffre C, Lunven C.

Thromb Haemost. 1994 Sep;72(3):381-6.

PMID:
7855788
[PubMed - indexed for MEDLINE]
8.
9.

Direct thrombin inhibitors.

Kaplan KL.

Expert Opin Pharmacother. 2003 May;4(5):653-66. Review.

PMID:
12739991
[PubMed - indexed for MEDLINE]
10.

Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1.

Riewald M, Kravchenko VV, Petrovan RJ, O'Brien PJ, Brass LF, Ulevitch RJ, Ruf W.

Blood. 2001 May 15;97(10):3109-16.

PMID:
11342437
[PubMed - indexed for MEDLINE]
Free Article
11.

Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.

Ouimet T, Lancelot E, Hyafil F, Rienzo M, Deux F, Lemaître M, Duquesnoy S, Garot J, Roques BP, Michel JB, Corot C, Ballet S.

Mol Pharm. 2012 Apr 2;9(4):850-61. doi: 10.1021/mp2003863. Epub 2012 Mar 8.

PMID:
22352457
[PubMed - indexed for MEDLINE]
12.

In vivo near infrared fluorescence (NIRF) intravascular molecular imaging of inflammatory plaque, a multimodal approach to imaging of atherosclerosis.

Calfon MA, Rosenthal A, Mallas G, Mauskapf A, Nudelman RN, Ntziachristos V, Jaffer FA.

J Vis Exp. 2011 Aug 4;(54). pii: 2257. doi: 10.3791/2257.

PMID:
21847078
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Measuring direct thrombin inhibitors with routine and dedicated coagulation assays: which assay is helpful?

Curvers J, van de Kerkhof D, Stroobants AK, van den Dool EJ, Scharnhorst V.

Am J Clin Pathol. 2012 Oct;138(4):551-8.

PMID:
23010710
[PubMed - indexed for MEDLINE]
Free Article
14.

Synergistic effect of thrombin and CD40 ligand on endothelial matrix metalloproteinase-10 expression and microparticle generation in vitro and in vivo.

Martínez de Lizarrondo S, Roncal C, Calvayrac O, Rodríguez C, Varo N, Purroy A, Lorente L, Rodríguez JA, Doeuvre L, Hervás-Stubbs S, Angles-Cano E, Páramo JA, Martínez-González J, Orbe J.

Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1477-87. doi: 10.1161/ATVBAHA.112.248773. Epub 2012 Apr 5.

PMID:
22492089
[PubMed - indexed for MEDLINE]
Free Article
15.

Detection of early stage atherosclerotic plaques using PET and CT fusion imaging targeting P-selectin in low density lipoprotein receptor-deficient mice.

Nakamura I, Hasegawa K, Wada Y, Hirase T, Node K, Watanabe Y.

Biochem Biophys Res Commun. 2013 Mar 29;433(1):47-51. doi: 10.1016/j.bbrc.2013.02.069. Epub 2013 Feb 26.

PMID:
23485468
[PubMed - indexed for MEDLINE]
16.

Ratiometric activatable cell-penetrating peptides provide rapid in vivo readout of thrombin activation.

Whitney M, Savariar EN, Friedman B, Levin RA, Crisp JL, Glasgow HL, Lefkowitz R, Adams SR, Steinbach P, Nashi N, Nguyen QT, Tsien RY.

Angew Chem Int Ed Engl. 2013 Jan 2;52(1):325-30. doi: 10.1002/anie.201205721. Epub 2012 Oct 18.

PMID:
23080482
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Relative importance of proteinase-activated receptor-1 versus matrix metalloproteinases in intracerebral hemorrhage-mediated neurotoxicity in mice.

Xue M, Hollenberg MD, Demchuk A, Yong VW.

Stroke. 2009 Jun;40(6):2199-204. doi: 10.1161/STROKEAHA.108.540393. Epub 2009 Apr 9.

PMID:
19359644
[PubMed - indexed for MEDLINE]
Free Article
18.

Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides.

Aguilera TA, Olson ES, Timmers MM, Jiang T, Tsien RY.

Integr Biol (Camb). 2009 Jun;1(5-6):371-81. doi: 10.1039/b904878b. Epub 2009 May 11.

PMID:
20023744
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.

Silvola JM, Saraste A, Laitinen I, Savisto N, Laine VJ, Heinonen SE, Ylä-Herttuala S, Saukko P, Nuutila P, Roivainen A, Knuuti J.

JACC Cardiovasc Imaging. 2011 Dec;4(12):1294-301. doi: 10.1016/j.jcmg.2011.07.009.

PMID:
22172786
[PubMed - indexed for MEDLINE]
Free Article
20.

The effects of direct thrombin inhibition with dabigatran on plaque formation and endothelial function in apolipoprotein E-deficient mice.

Lee IO, Kratz MT, Schirmer SH, Baumhäkel M, Böhm M.

J Pharmacol Exp Ther. 2012 Nov;343(2):253-7. doi: 10.1124/jpet.112.194837. Epub 2012 Jul 25.

PMID:
22837011
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk